For US Healthcare Professionals
For US Healthcare Professionals
IN ACTIVE PSORIATIC ARTHRITIS
TREMFYA® access has improved for 2021—see where it has preferred first-line access without biologic step edits* by entering a ZIP code below.†
Janssen Link offers eligible patients TREMFYA® at no cost until their commercial insurance covers the medication. See program requirements at JanssenCarePath.com/Tremfya/Janssen-Link.
*Requiring no step edits indicates a drug will be given first-line biologic access and will not require stepping through other biologic therapies.
†The information provided is not a guarantee of coverage or payment (partial or full). Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures. This document is presented for informational purposes only and is not intended to provide reimbursement or legal advice, nor does it promise or guarantee coverage, levels of reimbursement, payment, or charge. It is not intended to increase or maximize reimbursement by any payer. Laws, regulations, and policies concerning reimbursement are complex and are updated frequently. While we have made an effort to be current as of the issue date of this document, the information may not be as current or comprehensive when you view it. Please refer to the applicable plan’s website, or contact the plan for more information about coverage or any restrictions or prerequisites that may apply. We strongly recommend you consult the payer organization for its reimbursement policies. All information is subject to change. Nothing herein may be construed as an endorsement, approval, recommendation, representation, or warranty of any kind by any plan or insurer referenced herein. This communication is solely the responsibility ofJanssen Biotech, Inc.
At Janssen, we are dedicated to ensuring that once their provider makes the clinical decision to prescribe TREMFYA®, patients are able to receive their medication. The TREMFYA® So Simple Trial Program provides patients their first dose of TREMFYA® so they may determine with their provider if it is right for them.
FOR COMMERCIALLY INSURED PATIENTS
Janssen CarePath Savings Program. If commercial insurance coverage is approved, your patients may be eligible for the Janssen CarePath Savings Program.
Janssen Link. If commercial insurance coverage is delayed >5 business days or denied, your patients may be eligible for the Janssen Link program.
We can help make it simple for you to help your patients
Your one source for access, affordability, and treatment support for your patients
Janssen CarePath helps verify insurance coverage for your patients, provides reimbursement information, helps find financial assistance options for eligible patients, and provides ongoing support to help patients start and stay on TREMFYA® that you prescribed.
Call a Janssen CarePath Care Coordinator at 877-CarePath (877-227-3728), Monday-Friday, 8:00 AM to 8:00 PM ET.
Complete the registration form below to receive the latest updates from BioCoordiNATION® as well as important information to support the treatment of your patients.